Loading
institutionsInstitution
Aichi Cancer Center
Nagoya's prefectural cancer centre with a research institute known for cancer epidemiology, molecular carcinogenesis and gastrointestinal oncology.
Also called: 愛知県がんセンター
Overview
Aichi Cancer Center was founded in 1964 as a prefectural cancer hospital with an integrated research institute and is one of Japan's core cancer centres. Its Research Institute has a long tradition in cancer epidemiology (the HERPACC hospital-based case-control study), molecular carcinogenesis and the biology of gastric and lung cancer, including early ALK and EGFR resistance work, while the hospital is a leading Japanese site for gastric, oesophageal, colorectal, breast and haematological cancer trials and endoscopic resection. It participates in JCOG and WJOG and in the SCRUM-Japan genomic screening network. Patients can access a comprehensive genome profiling service and early-phase trials.
Location
Nagoya, JP
Type
cancer center
Archived website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#287 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Aichi Cancer Center, including child institutions. 657 works · 8,832 citations · 73% open access · 20% clinical trials · 1% reviews.
Oncology works per year
1252022
1432023
1602024
1262025
1032026
Most works
- Kei Muro71 works
- Toshiki Masuishi67 works
- Takayuki Yoshino64 works
- Manabu Shiozawa47 works
- Koji Komori45 works
- Yoshito Komatsu43 works
- Eiji Oki43 works
- Hiroji Iwata40 works
- Kentaro Yamazaki35 works
- Takeshi Kato35 works
Most cited
- Cancer epidemiology (HERPACC)
- Gastrointestinal oncology
- Breast cancer
- Molecular carcinogenesis
Similar pages
- PersonHaruhiko Fukuda
Shares Japan Clinical Oncology Group (JCOG), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer, Non-small-cell lung cancer.
- InstitutionOsaka International Cancer Institute
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- CompanyLucence
Shares ALK, EGFR, Comprehensive genomic profiling, HR-positive / HER2-negative breast cancer.
- InstitutionKyushu University Hospital
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- InstitutionKeio University Hospital
Shares Japan Clinical Oncology Group (JCOG), Comprehensive genomic profiling, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- CompanyInivata
Shares ALK, EGFR, Comprehensive genomic profiling, HR-positive / HER2-negative breast cancer.
- InstitutionNational Cancer Center Hospital East
Shares Japan Clinical Oncology Group (JCOG), ALK, Comprehensive genomic profiling, Oesophageal cancer.
- CollectionLUNGevity Foundation (and GO2 for Lung Cancer)
Shares ALK, EGFR, Comprehensive genomic profiling, Non-small-cell lung cancer.